News Focus
News Focus
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 1477

Thursday, 05/07/2020 5:07:44 PM

Thursday, May 07, 2020 5:07:44 PM

Post# of 9090
RVNC 1Q20 results—3/31/20 cash=$511M:

https://investors.revance.com/news-releases/news-release-details/revance-reports-first-quarter-2020-financial-results-provides

2020 operating cash burn is expected to be at the low end of the prior guidance range of $220-230M due to one-quarter delay (to 3Q20) in the US launch of Teoxane’s dermal fillers.

MYL’s decision whether to opt in for the Botox-biosimilar program is expected by the end of May.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”